Nicox annonce l’approbation de ZERVIATE en Chine
September 18, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox annonce l’approbation de ZERVIATE en Chine Ocumension Therapeutics, partenaire licencié de Nicox, a reçu l'approbation de la demande d'autorisation de mise sur le marché en...
Nicox Announces Approval of ZERVIATE in China
September 18, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will...
FLEX-O SIGNE UNE TROISIÈME IMPLANTATION DANS LA CAPITALE AVEC FLEX-O PARIS HAUSSMANN
September 11, 2024 11:29 ET
|
GROUPE COURTIN
Après avoir annoncé son implantation au 47 rue de Monceau et au 42-44 rue de Rome, FLEX-O annonce sa 3e implantation à Paris avec « FLEX-O PARIS HAUSSMANN», une adresse prestigieuse située au 69...
PlusInvesting Launches New Feature to Enhance Trading Efficiency for Canadian Users
September 09, 2024 07:29 ET
|
PlusInvesting
London,UK , Sept. 09, 2024 (GLOBE NEWSWIRE) -- PlusInvesting, a leading platform in the cryptocurrency trading industry, is proud to announce the launch of its latest feature designed to further...
Nasdaq Halts BAIYU Holdings, Inc.
September 06, 2024 11:04 ET
|
Nasdaq, Inc.
NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted on September 5, 2024 in BAIYU Holdings, Inc. (Nasdaq: BYU) at 19:50:00 Eastern...
Next Generation Sequencing Market is Anticipated to Attain USD 92.2 Billion in Revenue by 2033 , at a CAGR 23.8%: Insights by Dimension Market Research
September 04, 2024 11:36 ET
|
Dimension Market Research
New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Sequencing Market size is expected to reach USD 13.5 billion by 2024 and it is further anticipated to reach a...
66.2% of the Survey Respondents Believe M&A Deals Can Boost the Market Share: GoodFirms Research
September 04, 2024 09:30 ET
|
GoodFirms
Washington, Sept. 04, 2024 (GLOBE NEWSWIRE) -- GoodFirms, a universally renowned B2B ratings and reviews platform, released its recent survey research report, "The impact of mergers and...
ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi
September 04, 2024 08:00 ET
|
ALX Oncology
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that...
Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration
September 04, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration Christine Placet est Directrice Financière chez Theranexus, et a été...
Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board
September 04, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Christine Placet is CFO of Theranexus, and was formerly CEO of Horama and TrophosMichele...